Bi Pharma

Bi Pharma company information, Employees & Contact Information

Updated May 2026

Quick answer

Bi Pharma is a Pharmaceutical Manufacturing company and founded in 2016. It has approximately 27 employees on record. Contact data was last refreshed in May 2026. Find Bi Pharma's verified employee emails, phone numbers, headquarters address, and key decision makers below.

Explore related pages

Related company profiles:

Bi Pharma est un prestataire de l'industrie pharmaceutique proposant des services opérationnels uniques : 1. BI Pharma Distribution (depuis 2016) : votre solution logistique. Nous gérons la distribution et la promotion avec notre partenaire Sophar de vos produits de santé sur l'Outremer et la métropole. 2 . BI Pharma RH (depuis 2017) : vous accompagner dans l'externalisation de vos postes siège ou terrain pour des missions de moyenne durée pour des profils nécessitant une expérience ou un profil pas si simple à trouver (ex : vacancy, phase pilote/test, ...). Notre partenariat avec le cabinet CDG Conseil nous permet d'identifier le bon candidat dans des délais rapides. 3. BI Pharma Intelligence Economique (depuis 2018) : nous proposons des missions d'intelligence économique spécialisées santé grâce à notre logiciel propriétaire e-perion et notre équipe d'analystes : cartographie 360° (société, environnement, partenaire ...), stratégie e-santé (veille, e-reputation, cyber-sécurité ...). N'hésitez pas à nous contacter pour plus d'informations. contact@bipharma.net

Company Details

Employees
27
Founded
2016
Address
3 Rue Des Batignolles, Paris,île-De-France 75017,france
Industry
Pharmaceutical Manufacturing
NAICS
Pharmaceutical and Medicine Manufacturing
Medicinal and Botanical Manufacturing
Pharmaceutical Preparation Manufacturing
In-Vitro Diagnostic Substance Manufacturing
Biological Product (except Diagnostic) Manufacturing
HQ
Paris, Île-de-France
Looking for a particular Bi Pharma employee's phone or email?

Bi Pharma Questions

News

Egypt: Alex Pharma’s net profits increase 5.3% YoY in Q1 FY2025/26 - ZAWYA

Egypt: Alex Pharma’s net profits increase 5.3% YoY in Q1 FY2025/26 ZAWYA

Sun Pharma net profit falls on US antitrust settlement, drug impairment costs - Mint

Sun Pharma net profit falls on US antitrust settlement, drug impairment costs Mint

Destocking drags down Piramal Pharma Q1 performance, reports net loss of ₹82 cr - ETPharma.com

Destocking drags down Piramal Pharma Q1 performance, reports net loss of ₹82 cr ETPharma.com

Aurobindo Pharma net profit drops 10 percent to Rs 824 crore in Q1 - Medical Dialogues

Aurobindo Pharma net profit drops 10 percent to Rs 824 crore in Q1 Medical Dialogues

Indies Pharma Net Profits Dip To $7.2 Million - RJR News

Indies Pharma Net Profits Dip To $7.2 Million RJR News

Saudi: Jamjoom Pharma’s net profits near $105.6mln in 9M-25 - ZAWYA

Saudi: Jamjoom Pharma’s net profits near $105.6mln in 9M-25 ZAWYA

Mankind Pharma net drops 17.4% YoY to Rs 445 crore in Q1FY26 - Moneycontrol

Mankind Pharma net drops 17.4% YoY to Rs 445 crore in Q1FY26 Moneycontrol

Sun Pharma Q1 net profit falls 20% Y-o-Y; revenue rises 9% - Business Standard

Sun Pharma Q1 net profit falls 20% Y-o-Y; revenue rises 9% Business Standard

Ajanta Pharma Q1 Net Profit Rises 4% To Rs 255 Crore - NDTV Profit

Ajanta Pharma Q1 Net Profit Rises 4% To Rs 255 Crore NDTV Profit

Torrent Pharma Q1 Results: Net profit jumps 20% to Rs 548 crore - The Economic Times

Torrent Pharma Q1 Results: Net profit jumps 20% to Rs 548 crore The Economic Times

Fredun Pharma Q1 Results: Net up 64% on robust demand, product diversification - BusinessLine

Fredun Pharma Q1 Results: Net up 64% on robust demand, product diversification BusinessLine

Sun Pharma Q4 revenue nears ₹13000 cr, weak US sales drags down net profit - ETPharma.com

Sun Pharma Q4 revenue nears ₹13000 cr, weak US sales drags down net profit ETPharma.com

Ajanta Pharma Net Profit Rises 4% to ₹255 Cr in Jun Qtr - outlookbusiness.com

Ajanta Pharma Net Profit Rises 4% to ₹255 Cr in Jun Qtr outlookbusiness.com

Sun Pharma Q1 Results: Net profit declines 20% to ₹2,279 crore; revenue up 9% - Mint

Sun Pharma Q1 Results: Net profit declines 20% to ₹2,279 crore; revenue up 9% Mint

Sun Pharma net profit drops 20% to Rs 2,279 crore in Q1 - Medical Dialogues

Sun Pharma net profit drops 20% to Rs 2,279 crore in Q1 Medical Dialogues

Sun Pharma Q4 net profit declines 19% to Rs 2,154 crore, firm declares Rs 5.50 dividend - Moneycontrol

Sun Pharma Q4 net profit declines 19% to Rs 2,154 crore, firm declares Rs 5.50 dividend Moneycontrol

Sun Pharma net profit jumps 15% to Rs 2,903 crore in Q3FY25 - The Economic Times

Sun Pharma net profit jumps 15% to Rs 2,903 crore in Q3FY25 The Economic Times

Ajanta Pharma net profit rises 4% to ₹255 cr in June qtr - BusinessLine

Ajanta Pharma net profit rises 4% to ₹255 cr in June qtr BusinessLine

Sun Pharma Q4 results: Net profit falls 19% to ₹2,153.9 cr, revenue up 8% - Business Standard

Sun Pharma Q4 results: Net profit falls 19% to ₹2,153.9 cr, revenue up 8% Business Standard

Sun Pharma net profit rises 15 percent to Rs 2903 crore in Q3 - Medical Dialogues

Sun Pharma net profit rises 15 percent to Rs 2903 crore in Q3 Medical Dialogues

Mankind Pharma drops 6% after net profit declines in Q3 - Moneycontrol

Mankind Pharma drops 6% after net profit declines in Q3 Moneycontrol

Mankind Pharma net profit drops 16% to Rs 385 crore in Q3FY25 - The Economic Times

Mankind Pharma net profit drops 16% to Rs 385 crore in Q3FY25 The Economic Times

Q4 Results Highlights: Sun Pharma earning call -US contributes 31.4% of Sun Pharma revenues - Moneycontrol

Q4 Results Highlights: Sun Pharma earning call -US contributes 31.4% of Sun Pharma revenues Moneycontrol

Piramal Pharma Q4 net profit jumps 52% to ₹154 crore; revenue up 8%, dividend declared - CNBC TV18

Piramal Pharma Q4 net profit jumps 52% to ₹154 crore; revenue up 8%, dividend declared CNBC TV18

Pharma’s path to Net Zero: Targeting Scope 3 emissions - Pharmaceutical Technology

Pharma’s path to Net Zero: Targeting Scope 3 emissions Pharmaceutical Technology

Aurobindo Pharma Q2 net profit rises 9% - Times of India

Aurobindo Pharma Q2 net profit rises 9% Times of India

Natco Pharma net profit jumps 83 percent to Rs 676 crore in Q2 - Medical Dialogues

Natco Pharma net profit jumps 83 percent to Rs 676 crore in Q2 Medical Dialogues

Top 5 largest US pharma firms’ net earnings topped $81.9 billion last year: watchdog - The Hill

Top 5 largest US pharma firms’ net earnings topped $81.9 billion last year: watchdog The Hill

Seven pharma CEOs announce new joint action to accelerate net zero healthcare - AstraZeneca

Seven pharma CEOs announce new joint action to accelerate net zero healthcare AstraZeneca

How COVID-19 Vaccines Changed Pharma Company Profits - Statista

How COVID-19 Vaccines Changed Pharma Company Profits Statista

Hyphens Pharma net profit grows to $10.76m in 2024 - Singapore Business Review

Hyphens Pharma net profit grows to $10.76m in 2024 Singapore Business Review

Hengrui Pharma's net profit increased by nearly 30% in the first half of the year, with innovative drug revenue reaching 7.57 billion yuan. - 富途牛牛

Hengrui Pharma's net profit increased by nearly 30% in the first half of the year, with innovative drug revenue reaching 7.57 billion yuan. 富途牛牛

BioSpace Looks at the Top 8 Biopharma Companies by Net Income - BioSpace

BioSpace Looks at the Top 8 Biopharma Companies by Net Income BioSpace

Top 10 pharma companies in India by market cap [2025] - Forbes India

Top 10 pharma companies in India by market cap [2025] Forbes India

Sun Pharma net up 16.5% at ₹2,524 crore on robust sales - Mint

Sun Pharma net up 16.5% at ₹2,524 crore on robust sales Mint

Senores Pharma reports ₹21 crore net profit in Q1 FY26 - ETPharma.com

Senores Pharma reports ₹21 crore net profit in Q1 FY26 ETPharma.com

Torrent Pharma Q1 Results: Net profits grow 20% to ₹548 cr - BusinessLine

Torrent Pharma Q1 Results: Net profits grow 20% to ₹548 cr BusinessLine

Torrent Pharma Q2FY25 results: Net profit rises 17%, misses estimates - Business Standard

Torrent Pharma Q2FY25 results: Net profit rises 17%, misses estimates Business Standard

Aurobindo Pharma net soars 80% in Q4 on higher revenue from formulations, flat API sales - The Hindu

Aurobindo Pharma net soars 80% in Q4 on higher revenue from formulations, flat API sales The Hindu

Strides Pharma Science Q2 Results: Firm posts net profit of Rs 93.66 crore - The Economic Times

Strides Pharma Science Q2 Results: Firm posts net profit of Rs 93.66 crore The Economic Times

Sun Pharma Consolidated December 2024 Net Sales at Rs 13,675.46 crore, up 10.46% Y-o-Y - Moneycontrol

Sun Pharma Consolidated December 2024 Net Sales at Rs 13,675.46 crore, up 10.46% Y-o-Y Moneycontrol

Natco Pharma net profit rises 59% in June quarter to ₹669 crore - The Hindu

Natco Pharma net profit rises 59% in June quarter to ₹669 crore The Hindu

Mayne Pharma’s net losses more than double - AFR

Mayne Pharma’s net losses more than double AFR

Piramal Pharma net loss narrows at Rs 88.64 crore in Q1 - Medical Dialogues

Piramal Pharma net loss narrows at Rs 88.64 crore in Q1 Medical Dialogues

Aurobindo Pharma stock falls 2% after Q1 results; check key numbers here - Business Standard

Aurobindo Pharma stock falls 2% after Q1 results; check key numbers here Business Standard

Sun Pharma Q1 Results: Net profit falls 2% to ₹2,022 crore; revenue rises 11% YoY - Mint

Sun Pharma Q1 Results: Net profit falls 2% to ₹2,022 crore; revenue rises 11% YoY Mint

Piramal Pharma posts Rs 4 crore net profit in Q3FY25 - The Economic Times

Piramal Pharma posts Rs 4 crore net profit in Q3FY25 The Economic Times

LEO Pharma commits to net-zero greenhouse gas emissions by 2050 - Via Ritzau

LEO Pharma commits to net-zero greenhouse gas emissions by 2050 Via Ritzau

Strides Pharma Q2 results: Net profit at Rs 93.7 cr, revenue up 20% - Business Standard

Strides Pharma Q2 results: Net profit at Rs 93.7 cr, revenue up 20% Business Standard

Gland Pharma Q3 result: Net profit rises 7% to Rs 205 cr as expenses drop - Business Standard

Gland Pharma Q3 result: Net profit rises 7% to Rs 205 cr as expenses drop Business Standard

OneSource Specialty Pharma reports consolidated net profit of Rs 98.50 crore in the March 2025 quarter - Business Standard

OneSource Specialty Pharma reports consolidated net profit of Rs 98.50 crore in the March 2025 quarter Business Standard

Sun Pharma net profit rises 40% to Rs 2,836 crore - The New Indian Express

Sun Pharma net profit rises 40% to Rs 2,836 crore The New Indian Express

Sun Pharma Q3 net profit rises 15% to Rs 2,903.4 crore, meets estimate; Rs 10.5 dividend declared - Moneycontrol

Sun Pharma Q3 net profit rises 15% to Rs 2,903.4 crore, meets estimate; Rs 10.5 dividend declared Moneycontrol

Sun Pharma Q4 preview: Analysts expect 18% jump in profit; check details - Business Standard

Sun Pharma Q4 preview: Analysts expect 18% jump in profit; check details Business Standard

Mankind Pharma net profit rockets 65% in Q4, board okays plan to raise ₹7,500 crore - CNBC TV18

Mankind Pharma net profit rockets 65% in Q4, board okays plan to raise ₹7,500 crore CNBC TV18

Sun Pharma Q1 net profit drops 20% to Rs 2,279 crore due to exceptional charge; revenue up 9.5% - Moneycontrol

Sun Pharma Q1 net profit drops 20% to Rs 2,279 crore due to exceptional charge; revenue up 9.5% Moneycontrol

Torrent Pharma Q2 Results | Net profit up 17%, revenue grows 9% - CNBC TV18

Torrent Pharma Q2 Results | Net profit up 17%, revenue grows 9% CNBC TV18

Mankind Pharma Q1 Updates: Net profit down ~18% - India Infoline

Mankind Pharma Q1 Updates: Net profit down ~18% India Infoline

Suven Pharma Q2 Results: Net profit rises 3% to Rs 82 crore - The Economic Times

Suven Pharma Q2 Results: Net profit rises 3% to Rs 82 crore The Economic Times

Piramal Pharma Q1FY25 results: Net loss narrows at Rs 88.64 crore - Business Standard

Piramal Pharma Q1FY25 results: Net loss narrows at Rs 88.64 crore Business Standard

Natco Pharma's net profit rises 31.2% to Rs 420.3 cr in June quarter - Business Standard

Natco Pharma's net profit rises 31.2% to Rs 420.3 cr in June quarter Business Standard

Sun Pharma Q4 results: Net profit rises 34% to Rs 2,655 cr, revenue up 10% - Business Standard

Sun Pharma Q4 results: Net profit rises 34% to Rs 2,655 cr, revenue up 10% Business Standard

Glenmark Pharma reports net loss of Rs 331 cr in Q3 FY24 - Business Standard

Glenmark Pharma reports net loss of Rs 331 cr in Q3 FY24 Business Standard

Piramal Pharma Q2FY25 results: Net profit jumps over 4-fold to Rs 23 crore - Business Standard

Piramal Pharma Q2FY25 results: Net profit jumps over 4-fold to Rs 23 crore Business Standard

Piramal Pharma Q1 Results: Net loss narrows to Rs 89 crore - The Economic Times

Piramal Pharma Q1 Results: Net loss narrows to Rs 89 crore The Economic Times

Why did investors dump Marksans Pharma shares post Q4 results? Know here - Business Standard

Why did investors dump Marksans Pharma shares post Q4 results? Know here Business Standard

Alembic Pharma Q3 Results: Company posts 23% YoY decline in net profit at Rs 138 crore, revenue up 4% - The Economic Times

Alembic Pharma Q3 Results: Company posts 23% YoY decline in net profit at Rs 138 crore, revenue up 4% The Economic Times

Piramal Pharma Q3 Results | Net profit tanks 63% to ₹4 crore, revenue climbs 13% to ₹2,204 crore - CNBC TV18

Piramal Pharma Q3 Results | Net profit tanks 63% to ₹4 crore, revenue climbs 13% to ₹2,204 crore CNBC TV18

Sun Pharma net profit doubles in Q4 - The New Indian Express

Sun Pharma net profit doubles in Q4 The New Indian Express

Mankind Pharma Q2 results: Net profit rises to Rs 653 cr on higher demand - Business Standard

Mankind Pharma Q2 results: Net profit rises to Rs 653 cr on higher demand Business Standard

Meet Juneja Brothers: How they built Rs 95,876 crore Mankind Pharma, India’s fourth largest pharma company - financialexpress.com

Meet Juneja Brothers: How they built Rs 95,876 crore Mankind Pharma, India’s fourth largest pharma company financialexpress.com

Natco Pharma net dips 68% in Q2 - Telangana Today

Natco Pharma net dips 68% in Q2 Telangana Today

Q1 Results Highlights: Aurobindo Pharma net profit falls 10.2% YoY to ₹825 crore; Godfrey Phillips to issue 2:1 bonus shares - Upstox

Q1 Results Highlights: Aurobindo Pharma net profit falls 10.2% YoY to ₹825 crore; Godfrey Phillips to issue 2:1 bonus shares Upstox

Torrent Pharma net zooms 3-fold to Rs 568 cr - BusinessLine

Torrent Pharma net zooms 3-fold to Rs 568 cr BusinessLine

Orchid Pharma net loss narrows to Rs 53.9 crore - Business Standard

Orchid Pharma net loss narrows to Rs 53.9 crore Business Standard

Top Bi Pharma Employees

Free Chrome Extension

Find emails, phones & company data instantly

Find verified emails from LinkedIn profiles
Get direct phone numbers & mobile contacts
Access company data & employee information
Works directly on LinkedIn - no copy/paste needed
Get Chrome Extension - Free

Aero Online

Your AI prospecting assistant